Evidence map›Paper›PMID 33805573›Full record

ReviewInternational journal of molecular sciences2021

Advances and Perspectives in Dental Pulp Stem Cell Based Neuroregeneration Therapies.

Jon Luzuriaga, Yurena Polo, Oier Pastor-Alonso, Beatriz Pardo-Rodríguez, Aitor Larrañaga, Fernando Unda, Jose-Ramon Sarasua, Jose Ramon Pineda, Gaskon Ibarretxe

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Decoding Dental Stem Cell Aging: Mechanisms, Therapeutic Strategies, and Beyond.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jon LuzuriagaDepartment of Cell Biology and Histology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.ORCID 0000-0002-1443-7057
Yurena PoloPolimerbio, Paseo Mikeletegi 83, 28009 Donostia-San Sebastián, Spain.
Oier Pastor-AlonsoDepartment of Neurology, University of California San Francisco, San Francisco, CA 94143, USA.
Beatriz Pardo-RodríguezDepartment of Cell Biology and Histology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.ORCID 0000-0002-7163-0726
Aitor LarrañagaGroup of Science and Engineering of Polymeric Biomaterials (ZIBIO Group), Department of Mining, Metallurgy Engineering and Materials Science, POLYMAT, University of the Basque Country (UPV/EHU), 48013 Bilbao, Spain.
Fernando UndaDepartment of Cell Biology and Histology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
Jose-Ramon SarasuaGroup of Science and Engineering of Polymeric Biomaterials (ZIBIO Group), Department of Mining, Metallurgy Engineering and Materials Science, POLYMAT, University of the Basque Country (UPV/EHU), 48013 Bilbao, Spain.ORCID 0000-0002-7468-2417
Jose Ramon PinedaDepartment of Cell Biology and Histology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.
Gaskon IbarretxeDepartment of Cell Biology and Histology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.ORCID 0000-0002-4961-7402

Funding

Euskal Herriko Unibertsitatea COLAB19/03; IKERTU-2020.0155Euskal Herriko Unibertsitatea GIU16/66; PPGA20/22Eusko Jaurlaritza Bikaintek Grant. 20-AF-W2-2018-00001Ministerio de Ciencia e Innovación PID2019-104766RB-C21; RYC-2013-13450
6 · The paper itself

Abstract

Human dental pulp stem cells (hDPSCs) are some of the most promising stem cell types for regenerative therapies given their ability to grow in the absence of serum and their realistic possibility to be used in autologous grafts. In this review, we describe the particular advantages of hDPSCs for neuroregenerative cell therapies. We thoroughly discuss the knowledge about their embryonic origin and characteristics of their postnatal niche, as well as the current status of cell culture protocols to maximize their multilineage differentiation potential, highlighting some common issues when assessing neuronal differentiation fates of hDPSCs. We also review the recent progress on neuroprotective and immunomodulatory capacity of hDPSCs and their secreted extracellular vesicles, as well as their combination with scaffold materials to improve their functional integration on the injured central nervous system (CNS) and peripheral nervous system (PNS). Finally, we offer some perspectives on the current and possible future applications of hDPSCs in neuroregenerative cell therapies.

Indexed as

Cell- and Tissue-Based TherapyCell DifferentiationDental PulpExtracellular VesiclesHumansNerve RegenerationNeurogliaStem CellsStem Cell TransplantationTissue EngineeringTissue Scaffoldscell therapydental pulp stem cellsextracellular vesiclesimmunomodulationneural markersneuronal differentiationneuroprotectionneuroregenerationscaffoldstissue engineering

Identifiers

PMID33805573
PMCPMC8036729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.